Dregeoside Da1 is primarily studied for its potential anti-inflammatory and immunomodulatory effects. It has shown activity in reducing pro-inflammatory cytokines, making it a candidate for research in inflammatory diseases such as arthritis and certain autoimmune conditions. Additionally, it exhibits antioxidant properties, which may contribute to cellular protection against oxidative stress. Preliminary studies suggest possible benefits in metabolic health, including glucose regulation, indicating potential relevance in diabetes-related research. Its natural origin and bioactivity also make it of interest in the development of plant-based therapeutics and nutraceuticals.